Free Trial

VEON (VEON) Financials

VEON logo
$50.03 +0.53 (+1.07%)
Closing price 05/11/2026 04:00 PM Eastern
Extended Trading
$50.03 0.00 (0.00%)
As of 05/11/2026 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for VEON

Annual Income Statements for VEON

This table shows VEON's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-655 -4,491 -10,042 582 771 -349 674 -162 -2,065 974 532
Consolidated Net Income / (Loss)
-553 -4,583 -10,013 362 683 -316 801 -9.00 -2,450 487 591
Net Income / (Loss) Continuing Operations
-815 -6,371 -10,013 -617 582 94 120 733 687 902 591
Total Pre-Tax Income
-595 -5,736 -9,541 -248 1,132 373 464 802 866 1,119 785
Total Operating Income
524 -5,701 -9,308 554 1,865 823 1,023 1,163 765 934 1,439
Total Gross Profit
7,438 -86 -3,484 6,970 5,444 3,028 3,366 3,279 3,094 3,459 4,399
Total Revenue
9,606 2,545 -410 9,086 8,162 3,482 3,850 3,755 4,066 4,469 4,399
Total Cost of Revenue
2,168 2,631 3,074 2,116 2,718 454 484 476 972 1,010 0.00
Total Operating Expenses
6,914 5,615 5,824 6,416 4,312 2,205 2,343 2,204 2,329 2,525 2,672
Selling, General & Admin Expense
4,563 3,668 3,748 3,697 2,736 1,403 1,526 1,533 1,646 1,799 1,883
Depreciation Expense
1,550 1,439 1,491 1,339 1,512 553 605 557 527 529 578
Amortization Expense
517 497 537 495 - 177 194 221 208 199 224
Other Operating Expenses / (Income)
39 11 22 -30 - 0.00 -9.00 0.00 - - -22
Impairment Charge
245 - - 858 108 62 27 -107 -6.00 3.00 9.00
Total Other Income / (Expense), net
-1,119 -35 -233 -802 0.00 -450 -559 -542 101 185 -654
Interest Expense
829 - - 816 333 569 591 583 0.00 0.00 535
Interest & Investment Income
52 - - 67 1.00 19 13 32 - - 52
Other Income / (Expense), net
-342 -35 -233 -53 332 100 19 9.00 101 185 -171
Income Tax Expense
220 635 472 369 462 279 344 69 179 217 194
Net Income / (Loss) Discontinued Operations
262 1,788 - 979 101 -410 681 -742 -2,830 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
102 -92 29 -220 - 33 -127 -153 -78 -72 -59
Basic Earnings per Share
($0.37) $1.33 - $0.33 - ($0.20) $0.38 ($0.09) - - $0.30
Weighted Average Basic Shares Outstanding
- - 1.76B 1.76B 1.76B 1.76B 1.76B 1.76B 1.76B 1.85B 1.85B
Diluted Earnings per Share
($0.37) $1.33 - $0.33 - ($0.20) $0.38 ($0.09) - - $0.30
Weighted Average Diluted Shares Outstanding
- - 1.76B 1.76B 1.76B 1.76B 1.76B 1.76B 1.76B 1.85B 1.85B
Weighted Average Basic & Diluted Shares Outstanding
- - 1.76B 1.76B 1.76B 1.76B 1.76B 1.76B 1.76B 1.85B 1.85B

Quarterly Income Statements for VEON

No quarterly income statements for VEON are available.


Annual Cash Flow Statements for VEON

This table details how cash moves in and out of VEON's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-2,040 -922 -1,274 596 967 474 714 1,017 -1,271 -179 236
Net Cash From Operating Activities
2,033 1,875 2,475 2,515 2,830 2,443 2,638 2,738 2,131 1,159 318
Net Cash From Continuing Operating Activities
1,104 1,082 2,462 2,515 2,830 844 961 933 1,160 1,159 318
Net Income / (Loss) Continuing Operations
-595 288 328 -248 0.00 373 464 802 559 704 0.00
Depreciation Expense
1,550 2,128 2,094 2,692 - 792 826 671 729 731 811
Non-Cash Adjustments To Reconcile Net Income
-525 706 -227 -236 2,659 -321 550 -245 469 -389 -493
Net Cash From Investing Activities
-2,634 -2,671 -3,016 1,997 -1,582 -1,797 -1,122 -1,602 -2,036 -7.00 0.00
Net Cash From Continuing Investing Activities
-2,494 -1,738 -3,036 1,997 -1,582 -816 -909 -1,057 -1,020 -7.00 0.00
Net Cash From Financing Activities
-1,439 -126 -733 -3,916 -281 -103 -744 116 -1,339 -1,348 -82
Net Cash From Continuing Financing Activities
-734 -106 -733 -3,916 -281 174 -192 456 -919 -1,348 -82
Repurchase of Preferred Equity
- - - - - - - - - - -105
Other Financing Activities, net
2,303 -5.00 -259 0.00 - -1.00 -279 - - - 23
Cash Interest Received
- - - - 58 - - - - - 44

Quarterly Cash Flow Statements for VEON

No quarterly cash flow statements for VEON are available.


Annual Balance Sheets for VEON

This table presents VEON's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
21,193 19,484 14,102 16,059 14,551 15,921 15,083 8,218 8,036 9,215
Total Current Assets
4,550 3,164 3,110 2,499 2,850 3,553 3,981 3,158 2,813 3,113
Cash & Equivalents
2,942 1,314 1,808 1,250 1,669 2,252 3,107 1,902 1,689 1,732
Short-Term Investments
190 1,130 88 82 90 86 120 433 357 489
Accounts Receivable
685 - 577 628 572 690 456 542 448 601
Inventories, net
125 72 141 169 111 111 18 23 15 32
Current Deferred & Refundable Income Taxes
169 - 112 16 73 70 72 58 63 43
Other Current Assets
439 648 367 354 335 344 208 200 241 216
Plant, Property, & Equipment, net
6,719 6,237 4,932 7,340 6,879 6,717 0.00 0.00 0.00 0.00
Total Noncurrent Assets
9,899 5,239 6,077 6,220 670 5,651 8,254 2,162 2,207 2,345
Intangible Assets
2,257 - 5,670 5,688 - 3,244 1,960 1,619 1,510 1,549
Noncurrent Deferred & Refundable Income Taxes
343 336 197 134 186 228 274 312 368 418
Other Noncurrent Operating Assets
424 263 193 398 484 315 228 231 257 378
Other Noncurrent Nonoperating Assets
0.00 22 17 - 0.00 1,864 5,792 0.00 72 0.00
Total Liabilities & Shareholders' Equity
21,193 19,484 14,102 16,059 14,551 15,921 15,083 8,218 8,036 9,215
Total Liabilities
15,150 15,579 11,323 13,839 13,538 14,416 14,316 7,147 6,751 7,577
Total Current Liabilities
6,557 4,635 4,413 5,768 4,410 4,383 4,645 3,584 3,626 3,432
Short-Term Debt
3,046 1,268 1,289 2,585 1,255 1,242 2,844 1,692 1,666 1,102
Accounts Payable
1,744 1,544 1,624 1,847 1,946 2,031 1,087 1,200 1,276 1,442
Current Deferred & Payable Income Tax Liabilities
57 - 196 102 175 228 180 154 179 88
Other Current Liabilities
1,236 1,401 1,066 1,012 883 773 475 457 432 539
Other Current Nonoperating Liabilities
474 422 234 222 151 109 59 81 73 261
Total Noncurrent Liabilities
8,593 10,944 6,910 8,071 9,128 9,642 5,439 3,563 3,125 4,145
Noncurrent Deferred & Payable Income Tax Liabilities
331 376 180 141 127 115 36 26 27 41
Other Noncurrent Operating Liabilities
8,262 10,568 6,730 7,930 9,001 9,527 5,403 3,537 3,098 4,104
Other Noncurrent Nonoperating Liabilities
0.00 15 4.00 - 0.00 391 4,232 0.00 28 4.00
Total Equity & Noncontrolling Interests
6,043 3,890 2,779 2,220 1,013 1,505 767 1,071 1,257 1,634
Total Preferred & Common Equity
5,960 4,331 3,670 1,226 163 586 569 858 1,099 1,340
Total Common Equity
5,960 4,331 3,670 1,226 163 586 569 858 1,099 1,340
Other Equity Adjustments
5,960 4,331 3,670 1,226 163 586 569 858 1,099 1,340
Noncontrolling Interest
83 -441 -891 994 850 919 198 213 158 294

Quarterly Balance Sheets for VEON

No quarterly balance sheets for VEON are available.


Annual Metrics And Ratios for VEON

This table displays calculated financial ratios and metrics derived from VEON's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - - - - - - - 1,849,190,667.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 1,849,190,667.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.29
Growth Metrics
- - - - - - - - - - -
Profitability Metrics
- - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)
367 -3,991 -6,516 388 1,104 207 265 1,063 632 768 1,083
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - 26.27% 39.60%
Earnings before Interest and Taxes (EBIT)
182 -5,736 -9,541 501 2,197 923 1,042 1,441 1,030 1,141 1,268
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2,249 -3,608 -7,447 3,193 3,709 1,715 1,868 2,112 1,759 1,872 2,079
Valuation Ratios
- - - - - - - - - - -
Leverage & Solvency
- - - - - - - - - - -
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -8,218 -574 -3,720 -198 7,394 -2,272 4,073 -944 489 1,950
Efficiency Ratios
- - - - - - - - - - -
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
0.00 4,227 -1,715 2,393 3,695 -3,492 -955 -3,965 -2,389 -2,110 -2,977
Increase / (Decrease) in Invested Capital
0.00 4,227 -5,942 4,108 1,302 -7,187 2,537 -3,010 1,576 279 -867
Book Value per Share
$0.00 $0.00 $2.47 $2.09 $0.70 $0.09 $0.33 $0.32 $0.49 $0.63 $0.72
Tangible Book Value per Share
$0.00 $0.00 ($0.16) ($1.14) ($2.54) $0.09 ($1.51) ($0.79) ($0.43) ($0.23) ($0.11)
Total Capital
0.00 9,089 5,158 4,068 4,805 2,268 2,747 3,611 2,763 2,923 2,736
Total Debt
0.00 3,046 1,268 1,289 2,585 1,255 1,242 2,844 1,692 1,666 1,102
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
0.00 -2,265 -1,176 -607 1,253 -504 -1,096 -383 -643 -380 -1,119
Capital Expenditures (CapEx)
2,189 1,651 2,037 1,948 1,582 550 699 634 766 525 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -2,093 -2,647 -1,910 -2,016 -2,064 -1,926 -1,047 -1,069 -1,178 -1,438
Debt-free Net Working Capital (DFNWC)
0.00 1,039 -203 -14 -684 -305 412 2,180 1,266 868 783
Net Working Capital (NWC)
0.00 -2,007 -1,471 -1,303 -3,269 -1,560 -830 -664 -426 -798 -319
Net Nonoperating Expense (NNE)
920 592 3,497 26 421 523 -536 1,072 3,082 281 492
Net Nonoperating Obligations (NNO)
0.00 -1,816 -5,605 -386 1,475 -4,505 -2,460 -4,732 -3,460 -3,367 -4,611
Total Depreciation and Amortization (D&A)
2,067 2,128 2,094 2,692 1,512 792 826 671 729 731 811
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($7.00) $0.00 $9.00 ($5.00) $0.00 ($0.09) ($1.44) $0.23 $0.30
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 70.27M 70.27M 70.27M 70.27M 0.00 1.76B 1.76B 1.85B 1.85B
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($7.00) $0.00 $9.00 ($5.00) $0.00 ($0.09) ($1.44) $0.23 $0.30
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 70.27M 70.27M 70.27M 70.27M 0.00 1.76B 1.76B 1.85B 1.85B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 ($7.00) $0.00 $9.00 ($5.00) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 70.27M 70.27M 70.27M 70.27M 0.00 1.76B 1.76B 1.85B 1.85B
Normalized Net Operating Profit after Tax (NOPAT)
538 -3,991 -6,497 1,028 1,142 627 735 965 627 770 1,090
Debt Service Ratios
- - - - - - - - - - -
Payout Ratios
- - - - - - - - - - -

Quarterly Metrics And Ratios for VEON

No quarterly metrics and ratios for VEON are available.



Financials Breakdown Chart

VEON Financials - Frequently Asked Questions

According to the most recent income statement we have on file, VEON's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

VEON's net income appears to be on a downward trend, with a most recent value of $591 million in 2025, falling from -$553 million in 2015. The previous period was $487 million in 2024. View VEON's forecast to see where analysts expect VEON to go next.

VEON's total operating income in 2025 was $1.44 billion, based on the following breakdown:
  • Total Gross Profit: $4.40 billion
  • Total Operating Expenses: $2.67 billion

Over the last 10 years, VEON's total revenue changed from $9.61 billion in 2015 to $4.40 billion in 2025, a change of -54.2%.

VEON's total liabilities were at $7.58 billion at the end of 2025, a 12.2% increase from 2024, and a 50.0% decrease since 2016.

In the past 9 years, VEON's cash and equivalents has ranged from $1.25 billion in 2019 to $3.11 billion in 2022, and is currently $1.73 billion as of their latest financial filing in 2025.

Over the last 10 years, VEON's book value per share changed from 0.00 in 2015 to 0.72 in 2025, a change of 72.5%.



Financial statements for NASDAQ:VEON last updated on 3/19/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners